missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ AKT2 Monoclonal Antibody (95C657.1.2)

Mouse Monoclonal Antibody
Brand: Invitrogen™ MA141115
This item is not returnable.
View return policy
Description
Suggested positive control: HL-60 whole cell lysate, human placenta or HL-60, human Placenta protein, antigen standard for AKT2 (transient overexpression lysate). Immunogen sequence: VANSLKQRAP GEDPMDYK.
AKT2 is a phosphoinositide-dependent serine/threonine protein kinase that is enriched in insulin responsive tissues and has been implicated in the metabolic actions of the hormone. Akt is involved in many cellular signaling pathways and acts as a transducer of many functions initiated by growth factor receptors that activate phosphatidylinositol 3-kinase (PI 3-kinase). Akt2 is amplified and overexpressed in some human cancers.
Specifications
| AKT2 | |
| Monoclonal | |
| Conc. Not Determined | |
| Ascites, PBS with 0.5% BSA and 0.05% sodium azide | |
| P31751 | |
| Akt2 | |
| Synthetic peptide of human AKT2 (aa 106-123). | |
| RUO | |
| 208 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Flow Cytometry, Western Blot | |
| 95C657.1.2 | |
| Unconjugated | |
| Akt2 | |
| 2410016A19Rik; AKT serine/threonine kinase 2; Akt2; AKT2 kinase; AW554154; HIHGHH; murine thymoma viral (v-akt) homolog-2; murine thymoma viral (v-akt) oncogene homolog 2; PKB; PKB beta; PKBB; PKBBETA; PRKBB; protein kinase Akt-2; Protein kinase B beta; protein kinase B, beta; putative v-akt murine thymoma viral oncoprotein 2; rac protein kinase beta; RAC protein kinase beta RAC-PK beta; RAC-BETA; RAC-beta serine/threonine protein kinase; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; thymoma viral proto-oncogene 2; v-akt murine thymoma viral oncogene homolog 2 | |
| Mouse | |
| 200 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgM |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction